GoAI
Get started
JINS HOLDINGS Inc. logo

JINS HOLDINGS Inc.

3046.T

JPXHealthcareMedical - Instruments & Supplies

Open in GoAI

Latest quote

¥6,410

+¥30.00 · +0.47%

Aug 24, 1:22 PM JST

3046.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

JINS HOLDINGS Inc. is a Japanese corporation, operating through its subsidiaries, primarily involved in the design, manufacturing, wholesale, and retail of optical products and various fashion accessories. Its product portfolio includes a range of eyeglasses and lenses, alongside its innovative JINS MEME line, which allows users to monitor their physical and mental well-being. Beyond its core optical business, the firm also provides a selection of accessories for both genders, encompassing items like bags and headwear. Furthermore, it holds interests in agricultural contracting. JINS HOLDINGS maintains a global retail presence, with stores operating across Japan, mainland China, the U.S., Taiwan, and Hong Kong. Established in Tokyo, Japan, in 1988, the company operated as JINS Inc. until July 2019, when it adopted its current designation, JINS HOLDINGS Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
JP
CEO
Hitoshi Tanaka
Listed since
Sep 5, 2008
Employees
3,671

Market position

Day range

Current ¥6,410

52-week range

Current ¥6,410

Open
¥6,420
Previous close
¥6,380
Volume
94.2K
0.29× average
Average volume
322.6K
Average daily volume
Market cap
149.64B JPY
Beta
0.32
Market reference 1
50-day average
¥7,233.8
-11.39% below average
200-day average
¥6,320.83
+1.41% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
183.49B JPY
P/E (TTM)
18.06×
P/B (TTM)
4.19×
P/S (TTM)
1.38×
EV / EBITDA
12.2×
Earnings yield
4.45%
Free cash flow yield
4.56%
Dividend yield
1.65%

Profitability & efficiency

Gross margin
78.36%
Operating margin
11.28%
Net margin
7.66%
Return on equity
26.24%
Return on assets
14.26%
Return on invested capital
20.48%

Financial health

Debt / equity
0.22×
Current ratio
1.32×
Altman Z-score
5.74
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends82%53%23%-6%Gross margin, FY2021: 74.68%Gross margin, FY2022: 73.51%Gross margin, FY2023: 72.81%Gross margin, FY2024: 74.16%Gross margin, FY2025: 74.98%Operating margin, FY2021: 7.90%Operating margin, FY2022: 4.96%Operating margin, FY2023: 6.62%Operating margin, FY2024: 9.44%Operating margin, FY2025: 12.44%Net margin, FY2021: 5.15%Net margin, FY2022: 1.12%Net margin, FY2023: 2.41%Net margin, FY2024: 5.63%Net margin, FY2025: 8.57%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 74.68%. Gross margin FY2022 73.51%. Gross margin FY2023 72.81%. Gross margin FY2024 74.16%. Gross margin FY2025 74.98%. Operating margin FY2021 7.90%. Operating margin FY2022 4.96%. Operating margin FY2023 6.62%. Operating margin FY2024 9.44%. Operating margin FY2025 12.44%. Net margin FY2021 5.15%. Net margin FY2022 1.12%. Net margin FY2023 2.41%. Net margin FY2024 5.63%. Net margin FY2025 8.57%.

Income trends

Revenue

97.22B JPY+17.13%

Operating income

12.1B JPY+54.33%

Net income

8.33B JPY+78.33%
Income trends across reported periods106.86B JPY68.28B JPY29.69B JPY−8.9B JPYRevenue, FY2021: 63.9B JPYRevenue, FY2022: 66.9B JPYRevenue, FY2023: 73.26B JPYRevenue, FY2024: 83B JPYRevenue, FY2025: 97.22B JPYOperating income, FY2021: 5.05B JPYOperating income, FY2022: 3.32B JPYOperating income, FY2023: 4.85B JPYOperating income, FY2024: 7.84B JPYOperating income, FY2025: 12.1B JPYNet income, FY2021: 3.29B JPYNet income, FY2022: 750M JPYNet income, FY2023: 1.76B JPYNet income, FY2024: 4.67B JPYNet income, FY2025: 8.33B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 63.9B JPY. Revenue FY2022 66.9B JPY. Revenue FY2023 73.26B JPY. Revenue FY2024 83B JPY. Revenue FY2025 97.22B JPY. Operating income FY2021 5.05B JPY. Operating income FY2022 3.32B JPY. Operating income FY2023 4.85B JPY. Operating income FY2024 7.84B JPY. Operating income FY2025 12.1B JPY. Net income FY2021 3.29B JPY. Net income FY2022 750M JPY. Net income FY2023 1.76B JPY. Net income FY2024 4.67B JPY. Net income FY2025 8.33B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue97.22B JPY83B JPY73.26B JPY66.9B JPY63.9B JPY
Cost of goods sold24.32B JPY21.45B JPY19.92B JPY17.72B JPY16.18B JPY
Gross profit72.89B JPY61.55B JPY53.35B JPY49.18B JPY47.72B JPY
Research and development57M JPY124M JPY60M JPY167M JPY373M JPY
Selling, general, and administrative60.74B JPY53.59B JPY48.44B JPY45.7B JPY42.29B JPY
Operating expenses60.8B JPY53.71B JPY48.5B JPY45.87B JPY42.67B JPY
Interest income25M JPY17M JPY52M JPY86M JPY85M JPY
Interest expense155M JPY129M JPY141M JPY149M JPY162M JPY
Depreciation and amortization2.95B JPY2.93B JPY2.92B JPY2.95B JPY2.7B JPY
Operating income12.1B JPY7.84B JPY4.85B JPY3.32B JPY5.05B JPY
Net income8.33B JPY4.67B JPY1.76B JPY750M JPY3.29B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
45%
5 beats, 6 misses, 0 met estimates
Average EPS surprise
+8.80%
11 comparable reports
Latest EPS result
122.01
Estimate 122.85 · Miss by 0.68%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates128.8399.9471.0442.15Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Jan 10, 2025: actual 56.44, estimate 48.13, surprise +17.27%, Beat. Q2 2025, reported Apr 11, 2025: actual 105.74, estimate 83.65, surprise +26.41%, Beat. Q3 2025, reported Jul 11, 2025: actual 107.11, estimate 113.01, surprise -5.22%, Miss. Q4 2025, reported Oct 10, 2025: actual 90.56, estimate 93.28, surprise -2.92%, Miss. Q1 2026, reported Jan 9, 2026: actual 62.71, estimate 64.3, surprise -2.47%, Miss. Q2 2026, reported Apr 10, 2026: actual 82.65, estimate 64.25, surprise +28.64%, Beat. Q3 2026, reported Jul 10, 2026: actual 122.01, estimate 122.85, surprise -0.68%, Miss. Q4 2026, reported Oct 9, 2026: actual —, estimate 107.42, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates32.25B28.1B23.96B19.82BQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 10, 2025: actual 21.06B JPY, estimate 22.71B JPY, surprise -7.26%, Miss. Q2 2025, reported Apr 11, 2025: actual 23.78B JPY, estimate 23.37B JPY, surprise +1.75%, Beat. Q3 2025, reported Jul 11, 2025: actual 24.98B JPY, estimate 24.99B JPY, surprise -0.03%, Miss. Q4 2025, reported Oct 10, 2025: actual 27.4B JPY, estimate 27.58B JPY, surprise -0.67%, Miss. Q1 2026, reported Jan 9, 2026: actual 23.99B JPY, estimate 23.93B JPY, surprise +0.22%, Beat. Q2 2026, reported Apr 10, 2026: actual 26.53B JPY, estimate 26.25B JPY, surprise +1.06%, Beat. Q3 2026, reported Jul 10, 2026: actual 30.22B JPY, estimate 29.64B JPY, surprise +1.96%, Beat. Q4 2026, reported Oct 9, 2026: actual —, estimate 31.01B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥109

2025 complete year+67.7% since 2021

2026 partial: ¥47.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Aug 28, 2026

¥68.00

Semi-Annual

Record Aug 31, 2026 · Payment Aug 28, 2026

Dividend

Ex-dividend Feb 26, 2026

¥47.00

Semi-Annual

Record Feb 28, 2026 · Payment May 11, 2026

Dividend

Ex-dividend Aug 28, 2025

¥59.00

Semi-Annual

Record Aug 31, 2025 · Payment Nov 28, 2025

Dividend

Ex-dividend Feb 27, 2025

¥50.00

Semi-Annual

Record Feb 28, 2025 · Payment May 9, 2025

Dividend

Ex-dividend Aug 29, 2024

¥41.00

Semi-Annual

Record Aug 31, 2024 · Payment Nov 29, 2024

Dividend

Ex-dividend Feb 28, 2024

¥20.00

Semi-Annual

Record Feb 29, 2024 · Payment May 10, 2024

3046.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,009

-0.03%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,814

+0.87%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,000

+0.42%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,285

+0.74%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,396.5

+0.40%

ETFs holding 3046.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
267.32M
Weight
0.01%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.1+0.02%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
7.1M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
4.78M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
4.14M
Weight
0.00%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.85+0.86%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
1.8M
Weight
0.01%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.60+0.70%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
1.78M
Weight
0.01%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$160.06+0.43%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
1.45M
Weight
0.02%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%
WisdomTree Japan Hedged Equity Fund logoWisdomTree Japan Hedged Equity FundDXJ
Market value
1.29M
Weight
0.02%
AUM
7.11B USD
Expense ratio
0.48%
Price / 1D
$177.54+1.10%

Continue in GoAI

Research 3046.T

research.disclaimer